Study Design and Baseline Results in a Cohort Study to Identify Predictors for the Clinical Progression to Mild Cognitive Impairment or Dementia From Subjective Cognitive Decline (CoSCo) Study-Reference-Cited by-同舟云学术

Study Design and Baseline Results in a Cohort Study to Identify Predictors for the Clinical Progression to Mild Cognitive Impairment or Dementia From Subjective Cognitive Decline (CoSCo) Study

Published:2022 Issue:4 Volume:21 Page:147
ISSN:1738-1495
Container-title:Dementia and Neurocognitive Disorders
language:en
Short-container-title:Dement Neurocogn Disord

Author:

Ho SeongHee¹^ORCID,Hong Yun Jeong²^ORCID,Jeong Jee Hyang³^ORCID,Park Kee Hyung⁴^ORCID,Kim SangYun⁵⁶^ORCID,Wang Min Jeong⁷^ORCID,Choi Seong Hye⁸^ORCID,Han SeungHyun⁹,Yang Dong Won¹^ORCID

Affiliation:

1. Department of Neurology, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.

2. Department of Neurology, Uijeongbu St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Uijeongbu, Korea.

3. Department of Neurology, Ewha Womans University Seoul Hospital, Ewha Womans University School of Medicine, Seoul, Korea.

4. Department of Neurology, College of Medicine, Gachon University Gil Medical Center, Incheon, Korea.

5. Department of Neurology, Seoul National University College of Medicine, Seoul, Korea.

6. Clinical Neuroscience Center, Seoul National University Bundang Hospital, Seongnam, Korea.

7. ROA Neurology Clinic, Seongnam, Korea.

8. Department of Neurology, Inha University, School of Medicine, Incheon, Korea.

9. ROWAN Inc., Seoul, Korea.

Publisher

Korean Dementia Association

Subject

General Earth and Planetary Sciences,General Environmental Science

Link

https://dnd.or.kr/pdf/10.12779/dnd.2022.21.4.147

Reference47 articles.

1. A conceptual framework for research on subjective cognitive decline in preclinical Alzheimer's disease

2. The pre–mild cognitive impairment, subjective cognitive impairment stage of Alzheimer's disease

3. Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

4. Prevalence and risk of progression of preclinical Alzheimer’s disease stages: a systematic review and meta-analysis

5. Aducanumab: First Approval

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Longitudinal Study on Memory Enhancement in Subjective Cognitive Decline Patients: Clinical and Neuroimaging Perspectives;Journal of Alzheimer's Disease;2024-01-02

2. Relationship Between Amyloid Positivity and Sleep Characteristics in the Elderly With Subjective Cognitive Decline;Dementia and Neurocognitive Disorders;2024

3. Impacts of baseline biomarkers on cognitive trajectories in subjective cognitive decline: the CoSCo prospective cohort study;Alzheimer's Research & Therapy;2023-08-07

4. Impacts of baseline biomarkers on cognitive trajectories in subjective cognitive decline: The CoSCo prospective cohort study;2023-01-24

5. Validation of the Short Form of Korean-Everyday Cognition (K-ECog);Journal of Korean Medical Science;2023